pixantrone has been researched along with Cardiotoxicity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Menna, P; Minotti, G; Salvatorelli, E | 1 |
Boyle, EM; Morschhauser, F | 1 |
2 other study(ies) available for pixantrone and Cardiotoxicity
Article | Year |
---|---|
Do You Know Pixantrone?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Prednisone; Stem Cell Transplantation; Vincristine | 2017 |
Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma.
Topics: Animals; Antineoplastic Agents; Cardiotoxicity; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Time Factors; Treatment Outcome | 2015 |